These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9558034

  • 21. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Petite JP, Slama JL, Licht H, Lemerez M, Coste T, Andrieu J, Grimaud JC, Julien H, Dupuis J, Sallerin V.
    Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
    [Abstract] [Full Text] [Related]

  • 22. Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: a randomized, multicenter, double-masked trial.
    Dobrilla G, Piazzi L, Fiocca R.
    Clin Ther; 1999 Aug; 21(8):1321-32. PubMed ID: 10485504
    [Abstract] [Full Text] [Related]

  • 23. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [Abstract] [Full Text] [Related]

  • 24. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ, Jarvis B.
    Drugs; 2001 Sep; 61(12):1801-33. PubMed ID: 11693467
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
    Aoyama N, Kinoshita Y, Misaki F, Himeno S, Kasuga M, Chiba T.
    J Clin Gastroenterol; 1995 Sep; 20 Suppl 2():S86-9. PubMed ID: 7594351
    [Abstract] [Full Text] [Related]

  • 26. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial.
    Robinson M, Lanza F, Avner D, Haber M.
    Ann Intern Med; 1996 May 15; 124(10):859-67. PubMed ID: 8610914
    [Abstract] [Full Text] [Related]

  • 27. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 May 15; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 28. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
    Okai T, Ohtsubo K, Sakai J, Watanabe H, Motoo Y, Kawashima A, Sawabu N.
    Can J Gastroenterol; 2000 Oct 15; 14(9):761-6. PubMed ID: 11064311
    [Abstract] [Full Text] [Related]

  • 29. Factors affecting quality of ulcer healing after lansoprazole treatment.
    Ito G, Nakagawara M, Watanabe F, Ooi S, Nawano M, Hanai H, Kaneko E.
    J Clin Gastroenterol; 1995 Oct 15; 20 Suppl 2():S62-6. PubMed ID: 7594344
    [Abstract] [Full Text] [Related]

  • 30. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr 15; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical effectiveness of lansoprazole in patients with gastric ulcers: evaluation of quality of ulcer healing based on endoscopic ultrasonographic findings.
    Obara K, Kuwana T, Ishihata R, Kondo Y, Ejiri Y, Yokogi K, Okubo Y, Ajima H, Mukai S, Kasukawa R.
    J Clin Gastroenterol; 1995 Apr 15; 20 Suppl 2():S36-9. PubMed ID: 7594336
    [Abstract] [Full Text] [Related]

  • 33. Delayed-release lansoprazole plus naproxen.
    Curran MP, Wellington K.
    Drugs; 2004 Apr 15; 64(17):1915-9; discussion 1920-1. PubMed ID: 15329041
    [Abstract] [Full Text] [Related]

  • 34. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Hotz J, Kleinert R, Grymbowski T, Hennig U, Schwarz JA.
    Aliment Pharmacol Ther; 1992 Feb 15; 6(1):87-95. PubMed ID: 1543819
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 15; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 39. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
    Weaver AL, Gitlin N.
    Arch Intern Med; 2002 Oct 28; 162(19):2248-9. PubMed ID: 12390074
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.